Hypofrationated IGRT is a new treatment modality for early-stage non-small-cell lung cancer that has being intensively investigated mainly in academic centers in the United States, the European Union, and Japan.
        As an academic center, ECU Physicians Radiation Oncology is now offering this new promising treatment modality to inoperable patients by taking advantage of the Siemens Primatom's unique ability to visualize the tumor prior to each treatment. This allows us to make daily adjustments to the patient's position and minimize the chance of missing the tumor target.
        In selected cases, we are able to deliver in 5 treatments what traditionally involves 30 or more treatments. The short treatment course, or hypofractionated course, delivers significantly higher tumor control than the conventional longer treatment. This promising treatment modality offers hope to early stage lung cancer patients who can not undergo or refuse surgery.


Treatment Team:
        Patient Coordinator:  Theresa Parent, RN, BSN
        Radiation Oncology:   Hiram Gay M.D.

Referrals: Theresa Parent, RN, BSN 252-744-1789
Hypofractionated IGRT
for Early Stage Lung Cancer
Home
Contact Us
Directions
Radiation Therapy
Medical Physics
Medical Dosimetry
Research
Sponsored Workshops
Patient Resources
Clinical Trials
Common Questions
Appointments
Meet Your Team
Services
Publications
Quality Assurance
Versión en Español
General Information
Patients
Professionals
Future Students
Newsletter & Videos
News
Downloads
Your Cancer Center
Department of Radiation Oncology
The Brody School of Medicine at East Carolina University
600 Moye Blvd.
Greenville, NC 27834
Phone (252) 744-2900 / Fax (252) 744-2812
Contact Us
Disclaimer